A Randomized, Head-to-head, Single-blind Study to Compare the Response to Treatment with Subcutaneous Abatacept vs Adalimumab, on Background Methotrexate, in Adults with Early, Seropositive Rheumatoid Arthritis Who Have "Shared Epitope" HLA Class II Risk Alleles and Have an Inadequate Response to Methotrexate

Is this Study for You?

Let's Get Started!



Type of Study



Barbara Davis Center
University of Colorado Hospital

Principal Investigator
Photograph of Christopher Striebich,  MD, PhD

Christopher Striebich, MD, PhD

Study ID

Protocol Number: 21-3663

More information available at ClinicalTrials.gov: NCT04909801

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers